PMC7883711_01
A summary of the treatment history, relapses, and treatment of all 11 patients in the study. Initial onset of ON was not included in the determination of number of relapses in the study. AQP4: anti-aquaporin4 antibody; MOG: anti-myelin oligodendrocyte glycoprotein.
joph2020-8871146.001.jpg
PMC7883711_01_joph2020-8871146.001.jpg
fig1
 Figure 1 depicts relapse profiles of ON, myelitis, and encephalitis in all cases before and after the initiation of immunosuppressive therapy.